Source: Lab Bulletin

SPT Labtech: SPT Labtech and Synthace partner to accelerate drug discovery through accessible DOE

SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, and Synthace, the leading digital experiment platform for life science R&D teams, have announced a strategic collaboration to enhance the accessibility and effectiveness of Design of Experiments (DOE) in the life sciences community. This partnership combines the power of DOE with automated liquid handling to accelerate drug discovery and development timelines...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Rob Walton's photo - President & CEO of SPT Labtech

President & CEO

Rob Walton

CEO Approval Rating

82/100

Read more